An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems.
作者信息
Younus Manal Mohammed, Al-Jumaili Ali Azeez
机构信息
Director of Iraqi Pharmacovigilance Center, Ministry of Health, Baghdad, Iraq.
University of Baghdad College of Pharmacy, Baghdad, Iraq.
出版信息
Innov Pharm. 2021 Sep 22;12(4). doi: 10.24926/iip.v12i4.4294. eCollection 2021.
Abstract
摘要
相似文献
1
An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems.新冠疫苗安全性及上市后监测系统概述
Innov Pharm. 2021 Sep 22;12(4). doi: 10.24926/iip.v12i4.4294. eCollection 2021.
2
Assessing the Safety of COVID-19 Vaccines: A Primer.评估 COVID-19 疫苗的安全性：入门介绍。
Drug Saf. 2020 Dec;43(12):1205-1210. doi: 10.1007/s40264-020-01002-6. Epub 2020 Sep 30.
3
Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine.带状疱疹疫苗上市后初期安全性监测综述。
Vaccine. 2020 Apr 16;38(18):3489-3500. doi: 10.1016/j.vaccine.2019.11.058. Epub 2019 Dec 7.
4
Safety profile of - 17 years of GSK's passive post-marketing surveillance.葛兰素史克17年被动上市后监测的安全性概况。
Expert Rev Vaccines. 2020 Aug;19(8):771-779. doi: 10.1080/14760584.2020.1800458. Epub 2020 Aug 10.
5
Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China.免疫接种后不良事件报告率的系统评价：基于上市后监测计划的国际比较，并参考中国情况。
Vaccine. 2013 Jan 11;31(4):603-17. doi: 10.1016/j.vaccine.2012.11.051. Epub 2012 Nov 29.
6
Six-year multi-centre, observational, post-marketing surveillance of the safety of the HPV-16/18 AS04-adjuvanted vaccine in women aged 10-25 years in Korea.韩国针对10至25岁女性使用人乳头瘤病毒16/18 AS04佐剂疫苗安全性的六年多中心观察性上市后监测。
Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):837-842. doi: 10.1002/pds.4175. Epub 2017 Mar 7.
7
[Utilizing social media data in post-market safety surveillance].[在上市后安全监测中利用社交媒体数据]
Beijing Da Xue Xue Bao Yi Xue Ban. 2021 Jun 18;53(3):623-627. doi: 10.19723/j.issn.1671-167X.2021.03.031.
8
A multi-centre, post-marketing surveillance study of Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar TCV®) in India.一项在印度开展的 Vi 多糖-破伤风类毒素结合疫苗（Typbar TCV®）多中心、上市后监测研究。
Hum Vaccin Immunother. 2022 Dec 31;18(1):1947761. doi: 10.1080/21645515.2021.1947761. Epub 2021 Jul 9.
9
[Review of near real-time vaccine safety surveillance].
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Feb 10;42(2):351-356. doi: 10.3760/cma.j.cn112338-20200109-00024.
10
Post-marketing surveillance of live-attenuated Japanese encephalitis vaccine safety in China.中国流行性乙型脑炎减毒活疫苗上市后安全性监测
Vaccine. 2014 Oct 7;32(44):5875-9. doi: 10.1016/j.vaccine.2014.08.001. Epub 2014 Aug 28.
引用本文的文献
1
Unlocking insights: Navigating COVID-19 challenges and Emulating future pandemic Resilience strategies with strengthening natural immunity.解锁见解：应对新冠疫情挑战并通过增强自然免疫力效仿未来大流行的韧性策略。
Heliyon. 2024 Jul 17;10(15):e34691. doi: 10.1016/j.heliyon.2024.e34691. eCollection 2024 Aug 15.
2
Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges-A Narrative Review.疫苗的药物警戒：重要性、主要方面、前景与挑战——一篇叙述性综述
Pharmaceuticals (Basel). 2024 Jun 19;17(6):807. doi: 10.3390/ph17060807.
3
Global Safety Assessment of Adverse Events of Special Interest Following 2 Years of Use and 772 Million Administered Doses of mRNA-1273.在使用两年并接种7.72亿剂mRNA-1273后，对特定关注不良事件的全球安全性评估。
Open Forum Infect Dis. 2024 Feb 2;11(3):ofae067. doi: 10.1093/ofid/ofae067. eCollection 2024 Mar.
4
Lichen planus triggered by COVID-19 vaccination: A case series.新型冠状病毒肺炎疫苗接种引发的扁平苔藓：病例系列
J Family Med Prim Care. 2024 Jan;13(1):384-387. doi: 10.4103/jfmpc.jfmpc_664_23. Epub 2024 Feb 8.
5
Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data.BNT162b2 新冠病毒疫苗的安全性和反应原性：研发、上市后监测和真实世界数据。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2315659. doi: 10.1080/21645515.2024.2315659. Epub 2024 Feb 26.
6
Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea.瑞德西韦单抗治疗COVID-19的安全性和有效性：在韩国进行的4期上市后监测研究。
Infect Dis Ther. 2023 Oct;12(10):2417-2435. doi: 10.1007/s40121-023-00859-1. Epub 2023 Oct 13.
7
The Role of Adult Vaccines as Part of Antimicrobial Stewardship: A Scoping Review.成人疫苗作为抗菌药物管理一部分的作用：一项范围综述
Antibiotics (Basel). 2023 Sep 10;12(9):1429. doi: 10.3390/antibiotics12091429.
本文引用的文献
1
Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities.正在进行和未来的 COVID-19 疫苗临床试验：挑战与机遇。
Lancet Infect Dis. 2021 Nov;21(11):e342-e347. doi: 10.1016/S1473-3099(21)00263-2. Epub 2021 May 18.
2
What Is the Difference Between Observed Association and Causal Association, Signals and Evidence? Examples Related to COVID-19.观察到的关联与因果关联、信号与证据之间的区别是什么？与新冠病毒相关的示例
Front Pharmacol. 2021 Jan 29;11:569189. doi: 10.3389/fphar.2020.569189. eCollection 2020.
3
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine.如何调查在COVID-19疫苗临床试验期间报告的严重不良事件。
Drug Saf. 2021 Jan;44(1):1-5. doi: 10.1007/s40264-020-01018-y. Epub 2020 Nov 21.
4
Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines.追求有效 SARS-CoV-2（COVID-19）疫苗的进展与困境。
Front Immunol. 2020 Oct 2;11:579250. doi: 10.3389/fimmu.2020.579250. eCollection 2020.
5
Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?上市后研究：在英国，它们能为 COVID-19 疫苗提供安全网吗？
BMJ Evid Based Med. 2022 Feb;27(1):1-6. doi: 10.1136/bmjebm-2020-111507. Epub 2020 Oct 21.
6
SARS-CoV-2 vaccines in development.正在研发中的 SARS-CoV-2 疫苗。
Nature. 2020 Oct;586(7830):516-527. doi: 10.1038/s41586-020-2798-3. Epub 2020 Sep 23.
7
Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review).迈向有效的 COVID-19 疫苗：更新、观点和挑战（综述）。
Int J Mol Med. 2020 Jul;46(1):3-16. doi: 10.3892/ijmm.2020.4596. Epub 2020 May 6.
8
Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology.21世纪应用布拉德福德·希尔标准：数据整合如何改变分子流行病学中的因果推断
Emerg Themes Epidemiol. 2015 Sep 30;12:14. doi: 10.1186/s12982-015-0037-4. eCollection 2015.
9
The environment and disease: association or causation? 1965.环境与疾病：关联还是因果关系？1965年。
J R Soc Med. 2015 Jan;108(1):32-7. doi: 10.1177/0141076814562718.
Zotero 插件